Rosenfeld Clint A, Sultatos Lester G
Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Lafayette, New Jersey 07843, USA.
Toxicol Sci. 2006 Apr;90(2):460-9. doi: 10.1093/toxsci/kfj094. Epub 2006 Jan 10.
For decades the interaction of the anticholinesterase organophosphorus compounds with acetylcholinesterase has been characterized as a straightforward phosphylation of the active site serine (Ser-203) which can be described kinetically by the inhibitory rate constant k(i). However, more recently certain kinetic complexities in the inhibition of acetylcholinesterase by organophosphates such as paraoxon (O,O-diethyl O-(p-nitrophenyl) phosphate) and chlorpyrifos oxon (O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) phosphate) have raised questions regarding the adequacy of the kinetic scheme on which k(i) is based. The present article documents conditions in which the inhibitory capacity of paraoxon towards human recombinant acetylcholinesterase appears to change as a function of oxon concentration (as evidenced by a changing k(i)), with the inhibitory capacity of individual oxon molecules increasing at lower oxon concentrations. Optimization of a computer model based on an Ordered Uni Bi kinetic mechanism for phosphylation of acetylcholinesterse determined k(1) to be 0.5 nM(-1)h(-1), and k(-1) to be 169.5 h(-1). These values were used in a comparison of the Ordered Uni Bi model versus a k(i) model in order to assess the capacity of k(i) to describe accurately the inhibition of acetylcholinesterase by paraoxon. Interestingly, the k(i) model was accurate only at equilibrium (or near equilibrium), and when the inhibitor concentration was well below its K(d) (pseudo first order conditions). Comparisons of the Ordered Uni Bi and k(i) models demonstrate the changing k(i) as a function of inhibitor concentrations is not an artifact resulting from inappropriate inhibitor concentrations.
几十年来,抗胆碱酯酶有机磷化合物与乙酰胆碱酯酶的相互作用一直被描述为活性位点丝氨酸(Ser-203)的直接磷酸化,其动力学可由抑制速率常数k(i)来描述。然而,最近,对氧磷(O,O-二乙基-O-(对硝基苯基)磷酸酯)和毒死蜱氧磷(O,O-二乙基-O-(3,5,6-三氯-2-吡啶基)磷酸酯)等有机磷酸酯抑制乙酰胆碱酯酶过程中的某些动力学复杂性,引发了人们对k(i)所基于的动力学方案是否充分的质疑。本文记录了这样的情况:对氧磷对人重组乙酰胆碱酯酶的抑制能力似乎会随着氧磷浓度的变化而改变(k(i)的变化证明了这一点),单个氧磷分子的抑制能力在较低的氧磷浓度下会增加。基于有序单双分子动力学机制对乙酰胆碱酯酶磷酸化进行优化的计算机模型确定k(1)为0.5 nM⁻¹h⁻¹,k(-1)为169.5 h⁻¹。这些值被用于比较有序单双分子模型和k(i)模型,以评估k(i)准确描述对氧磷抑制乙酰胆碱酯酶的能力。有趣的是,k(i)模型仅在平衡(或接近平衡)时,以及抑制剂浓度远低于其K(d)(伪一级条件)时才准确。有序单双分子模型和k(i)模型的比较表明,k(i)随抑制剂浓度的变化不是由不适当的抑制剂浓度导致的假象。